These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hyperlipidemia of diuretic therapy. Ames R. Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566 [Abstract] [Full Text] [Related]
23. [Pharmacological hypertension therapy]. Pedersen OL, Christensen KL, Bang LE, Ibsen H, Schultz-Larsen P. Ugeskr Laeger; 2009 Jun 08; 171(24):2022-5. PubMed ID: 19523367 [Abstract] [Full Text] [Related]
24. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar 08; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
25. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. Weinberger MH. Arch Intern Med; 1985 Jun 08; 145(6):1102-5. PubMed ID: 2860883 [Abstract] [Full Text] [Related]
26. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives]. Rouffy J, Chanu B, Bakir R, Sauvanet JP. J Pharmacol; 1983 Jun 08; 14 Suppl 2():183-99. PubMed ID: 6138467 [Abstract] [Full Text] [Related]
27. Drug therapy for hypertension in the elderly. Kligman EW, Higbee MD. J Fam Pract; 1989 Jan 08; 28(1):81-7. PubMed ID: 2563274 [Abstract] [Full Text] [Related]
28. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism. Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H. J Cardiovasc Pharmacol; 1987 Jan 08; 10 Suppl 10():S199-202. PubMed ID: 2455133 [Abstract] [Full Text] [Related]
29. Adverse effects of antihypertensive drug therapy on glucose intolerance. Houston MC. Cardiol Clin; 1986 Feb 08; 4(1):117-35. PubMed ID: 2871931 [Abstract] [Full Text] [Related]
30. Antihypertensive drugs and blood lipids: the Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. J Cardiovasc Pharmacol; 1982 Feb 08; 4 Suppl 2():S222-4. PubMed ID: 6177960 [Abstract] [Full Text] [Related]
31. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Itskovitz HD. Clin Ther; 1994 Feb 08; 16(3):490-504. PubMed ID: 7923316 [Abstract] [Full Text] [Related]
32. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Hypertens Res; 2007 Apr 08; 30(4):301-6. PubMed ID: 17541208 [Abstract] [Full Text] [Related]
33. Treatment of high blood pressure. From diuretics to the present and future. Nogueira da Costa J. Cardiologia; 1995 Dec 08; 40(12):893-8. PubMed ID: 8901039 [No Abstract] [Full Text] [Related]
34. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. Fogari R, Derosa G, Zoppi A, Rinaldi A, Preti P, Lazzari P, Mugellini A. Hypertens Res; 2008 Jan 08; 31(1):43-50. PubMed ID: 18360017 [Abstract] [Full Text] [Related]
35. The importance of blood pressure control. Jarvis SC. Prof Nurse; 2004 Nov 08; 20(3):48. PubMed ID: 15552441 [No Abstract] [Full Text] [Related]
37. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations? Hilgers KF, Mann JF. Nephrol Dial Transplant; 2008 Nov 08; 23(11):3389-91. PubMed ID: 18687734 [No Abstract] [Full Text] [Related]
39. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension]. Sawicki PT. Wien Klin Wochenschr; 1995 Sep 08; 107(21):629-39. PubMed ID: 8578749 [Abstract] [Full Text] [Related]
40. Pressor responses to antihypertensive drug types. Alderman MH, Cohen HW, Sealey JE, Laragh JH. Am J Hypertens; 2010 Sep 08; 23(9):1031-7. PubMed ID: 20725055 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]